UVEITIS
Clinical trials for UVEITIS explained in plain language.
Never miss a new study
Get alerted when new UVEITIS trials appear
Sign up with your email to follow new studies for UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New imaging study reveals how implant tames eye inflammation
Disease control CompletedThis study followed 30 uveitis patients who received a fluocinolone acetonide implant to control eye inflammation. Researchers used advanced imaging (OCT, OCTA, fluorescein angiography) to track changes in inflammation over 12 months. The goal was to see if imaging could better m…
Matched conditions: UVEITIS
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Biosimilar switch works for most patients in Real-World study
Disease control CompletedThis study tested what happens when patients with rheumatoid arthritis, Crohn's disease, or eye inflammation switch from the original drug Remicade to its lower-cost biosimilar Inflectra. Over 260 adults who had been on Remicade for at least 4 months were switched. The main goal …
Matched conditions: UVEITIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a gel tame eye inflammation? new trial tests ACTH for uveitis
Disease control CompletedThis study tested ACTH gel, given as a shot under the skin, in 28 people with non-infectious uveitis (eye inflammation not caused by an infection). The goal was to see if it is safe and can help control inflammation. Participants received one of two doses, and researchers tracked…
Matched conditions: UVEITIS
Phase: PHASE2 • Sponsor: Quan Dong Nguyen • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Head-to-Head trial tests biologics to save sight in stubborn uveitis
Disease control CompletedThis study tested three biologic drugs—adalimumab, anakinra, and tocilizumab—in 112 people with severe, treatment-resistant uveitis, an inflammatory eye disease that can cause blindness. Participants received one of the drugs for 16 weeks. The goal was to see which drug best redu…
Matched conditions: UVEITIS
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC
-
Drug shows promise for kids with Arthritis-Related eye disease
Disease control CompletedThis study tested the drug adalimumab against a placebo in 34 children with juvenile arthritis and active eye inflammation (uveitis) that wasn't controlled by steroid drops or methotrexate. The goal was to see if adalimumab could reduce eye inflammation after two months. After th…
Matched conditions: UVEITIS
Phase: PHASE2, PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 14:26 UTC
-
New DNA test could revolutionize diagnosis of eye infections
Diagnosis CompletedThis study tested a new method called metagenomic deep sequencing (MDS) to find the cause of eye infections. 100 adults with suspected infectious uveitis or endophthalmitis were randomly assigned to have their doctors receive MDS results or not, in addition to standard tests. The…
Matched conditions: UVEITIS
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
Could your gut bacteria be linked to eye disease?
Knowledge-focused CompletedThis study looked at the natural bacteria in the gut of 131 adults with and without uveitis, an inflammatory eye disease. Researchers collected stool and blood samples and performed eye exams to see if differences in gut bacteria are linked to eye inflammation. No treatment was g…
Matched conditions: UVEITIS
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Eye disease biobank seeks clues to uveitis
Knowledge-focused CompletedThis study collected blood, saliva, and eye fluid samples from 343 people with uveitis, an inflammatory eye disease that can cause vision loss. Researchers aimed to learn which genes and other factors might lead to the disease and affect treatment response. Participants were foll…
Matched conditions: UVEITIS
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to streamline uveitis diagnosis and cut costs
Knowledge-focused CompletedThis study looked at 905 people with uveitis, an eye inflammation, to see if a standardized step-by-step diagnostic plan works as well as letting doctors choose any tests they want. The goal was to find the cause of the uveitis more efficiently and at a lower cost. Researchers co…
Matched conditions: UVEITIS
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:32 UTC